Discovery of Inhibitors that Elucidate the Role of UCH-L1 Activity in the H1299 Lung Cancer Cell Line
Open Access
- 1 September 2003
- journal article
- research article
- Published by Elsevier BV in Cell Chemical Biology
- Vol. 10 (9), 837-846
- https://doi.org/10.1016/j.chembiol.2003.08.010
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- S18Y polymorphism in the UCH‐L1 gene and Parkinson's disease: Evidence for an age‐dependent relationshipMovement Disorders, 2002
- The UCH-L1 Gene Encodes Two Opposing Enzymatic Activities that Affect α-Synuclein Degradation and Parkinson's Disease SusceptibilityCell, 2002
- ACT and UCH‐L1 polymorphisms in Parkinson's disease and age of onsetMovement Disorders, 2002
- Interaction and colocalization of PGP9.5 with JAB1 and p27Kip1Oncogene, 2002
- No genetic association of the Ubiquitin Carboxy-terminal Hydrolase-L1 gene S18Y polymorphism with familial Parkinson's diseaseJournal of Neural Transmission, 2001
- Deubiquitinating Enzymes: Their Diversity and Emerging RolesBiochemical and Biophysical Research Communications, 1999
- A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening AssaysSLAS Discovery, 1999
- Substrate Binding and Catalysis by Ubiquitin C-Terminal Hydrolases: Identification of Two Active Site ResiduesBiochemistry, 1996
- Progressive degeneration of motor nerve terminals in GAD mutant mouse with hereditary sensory axonopathyNeuropathology and Applied Neurobiology, 1993
- Dying back type axonal degeneration of sensory nerve terminals in muscle spindles of the gracile axonal dystrophy (GAD) mutant mouseNeuropathology and Applied Neurobiology, 1992